Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

Free Research Reports on ACHN, CHTP, NSM and SQNM Issued by the Bedford Report Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit


Print article Print article
© Marketwire 2013
2013-01-08 14:52:33 -

NEW YORK, NY -- (Marketwire) -- 01/08/13 -- The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.



Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) shares fell 10 percent on nearly three times the average daily volume Monday after reporting interim results for ACH-3102, a treatment for Hepatitis C.



Find out more about Achillion Pharmaceuticals including full access to the free equity report at: www.BedfordReport.com/ACHN : www.bedfordreport.com/ACHN





Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) acquires and develops innovative products for the treatment of a variety of human diseases, including central nervous system disorders. Shares of the company have rallied over 25 percent in the past week.



Find out more about Chelsea Therapeutics including full access to the free equity report at: www.BedfordReport.com/CHTP : www.bedfordreport.com/CHTP



Nationstar Mortgage Holdings Inc. (NYSE: NSM) shares soared 17 percent on over 9 million shares traded Monday. The company reported that it has agreed to acquire approximately $215 billion in mortgage servicing assets from Bank of America.



Find out more about Nationstar Mortgage including full access to the free equity report at: www.BedfordReport.com/NSM : www.bedfordreport.com/NSM



Sequenom, Inc. (NASDAQ: SQNM) shares of the biotech company fell sharply in early morning trading Monday after it was reported Illumina Inc. agreed to purchase privately held Verinata Health, which also develops prenatal tests for Down syndrome.



Find out more about Sequenom including full access to the free equity report at: www.BedfordReport.com/SQNM : www.bedfordreport.com/SQNM



Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein.



A third party, Providence Media Strategies LLC has paid Equity News Circuit four hundred and fifty dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.




Contact Information:

Equity News Circuit
Email Contact : www2.marketwire.com/mw/emailprcntct?id=DA685CD8AE819DBA



Press Information:




Contact Person:


Disclaimer: (c) 2014 Market Wire. All of the press releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Market Wire's, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com